Evidence map›Paper›PMID 39677664›Full record

ArticlebioRxiv : the preprint server for biology2024

High-throughput discovery and deep characterization of cyclin-CDK docking motifs.

Mihkel Örd, Matthew J Winters, Mythili S Subbanna, Natalia de Martin Garrido, Victoria I Cushing, Johanna Kliche, Caroline Benz, Ylva Ivarsson, Basil J Greber, Peter M Pryciak and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Mihkel ÖrdUniversity of Cambridge, CRUK Cambridge Institute, Cambridge, UK.
Matthew J WintersDepartment of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Mythili S SubbannaDepartment of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Natalia de Martin GarridoThe Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.
Victoria I CushingThe Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.
Johanna KlicheDepartment of Chemistry - BMC, Uppsala University, Husargatan 3, 751 23 Uppsala, Sweden.
Caroline BenzDepartment of Chemistry - BMC, Uppsala University, Husargatan 3, 751 23 Uppsala, Sweden.
Ylva IvarssonDepartment of Chemistry - BMC, Uppsala University, Husargatan 3, 751 23 Uppsala, Sweden.ORCID 0000-0002-7081-3846
Basil J GreberThe Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.
Peter M PryciakDepartment of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
Norman E DaveyThe Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.

Funding

YEAST PHEROMONE SIGNAL TRANSDUCTIONR01GM057769 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PRYCIAK, PETER M · 1997 to 2023
$7.6M
Comprehensive Analysis of Peptide Motif Binding In VivoR01GM145795 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PRYCIAK, PETER M · 2022 to 2025
$1.3M
NIGMS NIH HHS R01 GM057769NIGMS NIH HHS R01 GM145795
6 · The paper itself

Abstract

Cyclin-CDKs are master regulators of cell division. In addition to directly activating the CDK, the cyclin subunit regulates CDK specificity by binding short peptide "docking" motifs in CDK substrates. Here, we measure the relative binding strength of ~100,000 peptides to 11 human cyclins from five cyclin families (D, E, A, B and F). Using a quantitative intracellular binding assay and large-scale tiled peptide screening, we identified a range of non-canonical binders that unveil a broader than anticipated repertoire of cyclin docking motif types. Structural and saturation mutagenesis studies revealed distinct binding modes and sequence features that govern motif recognition, binding strength, and cyclin preference. Docking motifs vary from highly selective to pan-cyclin, thereby fine-tuning the timing of CDK phosphorylation during cell cycle progression. Overall, these findings provide an unprecedented depth of understanding about the rules encoding specificity and affinity within a group of related but distinct protein domains.

Indexed as

binding affinitybinding specificitycyclincyclin-dependent kinasesenzyme dockingkinasephosphorylationpost-translational modificationshort linear motifSLiMs

Identifiers

PMID39677664
PMCPMC11643097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.